232 related articles for article (PubMed ID: 29241739)
21. Mutations in the RAS/RAF/MAP kinase pathway commonly occur in gallbladder adenomas but are uncommon in gallbladder adenocarcinomas.
Pai RK; Mojtahed K; Pai RK
Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):133-40. PubMed ID: 21307665
[TBL] [Abstract][Full Text] [Related]
22. Sialadenoma Papilliferum of the Bronchus: An Unrecognized Bronchial Counterpart of the Salivary Gland Tumor With Frequent BRAF V600E Mutations.
Nakaguro M; Mino-Kenudson M; Urano M; Ogawa I; Honda Y; Hirai H; Tanigawa M; Sukeda A; Kajiwara N; Ohira T; Ikeda N; Mikami Y; Tada Y; Ikeda JI; Matsubayashi J; Faquin WC; Sadow PM; Nagao T
Am J Surg Pathol; 2021 May; 45(5):662-671. PubMed ID: 33443864
[TBL] [Abstract][Full Text] [Related]
23. Somatic BRAF c.1799T>A p.V600E Mosaicism syndrome characterized by a linear syringocystadenoma papilliferum, anaplastic astrocytoma, and ocular abnormalities.
Watanabe Y; Shido K; Niihori T; Niizuma H; Katata Y; Iizuka C; Oba D; Moriya K; Saito-Nanjo Y; Onuma M; Rikiishi T; Sasahara Y; Watanabe M; Aiba S; Saito R; Sonoda Y; Tominaga T; Aoki Y; Kure S
Am J Med Genet A; 2016 Jan; 170A(1):189-94. PubMed ID: 26360803
[TBL] [Abstract][Full Text] [Related]
24. Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.
Kwon MJ; Kim JW; Jung JP; Cho JW; Nam ES; Cho SJ; Kim JS; Park HR; Min SK; Seo J; Min KW; Kim DH; Jeon JY
Hum Pathol; 2016 Apr; 50():90-100. PubMed ID: 26997442
[TBL] [Abstract][Full Text] [Related]
25. Syringocystadenoma papilliferum combined with a tubular apocrine adenoma.
Léda LDSB; Lins MDSVS; Leite EJDS; Cardoso AEC; Houly RLS
An Bras Dermatol; 2017; 92(5):721-723. PubMed ID: 29166517
[TBL] [Abstract][Full Text] [Related]
26. Tracing origin of serrated adenomas with BRAF and KRAS mutations.
Lee EJ; Choi C; Park CK; Maeng L; Lee J; Lee A; Kim KM
Virchows Arch; 2005 Sep; 447(3):597-602. PubMed ID: 15991007
[TBL] [Abstract][Full Text] [Related]
27. BRAF and RAS Mutational Status in Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and Invasive Subtype of Encapsulated Follicular Variant of Papillary Thyroid Carcinoma in Korea.
Kim M; Jeon MJ; Oh HS; Park S; Kim TY; Shong YK; Kim WB; Kim K; Kim WG; Song DE
Thyroid; 2018 Apr; 28(4):504-510. PubMed ID: 29439609
[TBL] [Abstract][Full Text] [Related]
28. PIK3CA Amplification Is Common in Left Side-Tubular Adenomas but Uncommon Sessile Serrated Adenomas Exclusively with KRAS Mutation.
Lee H; Lee JH; Kim DK; Choi IJ; Hwang I; Kang YN; Kim S
Int J Med Sci; 2015; 12(4):349-53. PubMed ID: 26019684
[TBL] [Abstract][Full Text] [Related]
29. KIT (CD117) Expression in Benign and Malignant Sweat Gland Tumors.
Nishida H; Daa T; Kashima K; Arakane M; Urabe S; Yoshikawa Y; Gamachi A; Yokoyama S
Am J Dermatopathol; 2015 Dec; 37(12):898-905. PubMed ID: 25634571
[TBL] [Abstract][Full Text] [Related]
30. Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary-like glands: report of a case and review of the literature.
Parks A; Branch KD; Metcalf J; Underwood P; Young J
Am J Dermatopathol; 2012 Feb; 34(1):104-9. PubMed ID: 22262361
[TBL] [Abstract][Full Text] [Related]
31. A potential role for targeted therapy in a subset of metastasizing adnexal carcinomas.
Dias-Santagata D; Lam Q; Bergethon K; Baker GM; Iafrate AJ; Rakheja D; Hoang MP
Mod Pathol; 2011 Jul; 24(7):974-82. PubMed ID: 21423156
[TBL] [Abstract][Full Text] [Related]
32. Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary-like glands.
Nishie W; Sawamura D; Mayuzumi M; Takahashi S; Shimizu H
J Cutan Pathol; 2004 Sep; 31(8):561-4. PubMed ID: 15268713
[TBL] [Abstract][Full Text] [Related]
33. [Molecular analysis of sporadic colon cancer].
Hurtado C; Wielandt AM; Zárate AJ; Kronberg U; Castro M; Yamagiwa K; Ito T; Eishi Y; Contreras L; López-Köstner F
Rev Med Chil; 2015 Mar; 143(3):310-9. PubMed ID: 26005817
[TBL] [Abstract][Full Text] [Related]
34. Colorectal neuroendocrine carcinomas and adenocarcinomas share oncogenic pathways. A clinico-pathologic study of 12 cases.
Karkouche R; Bachet JB; Sandrini J; Mitry E; Penna C; Côté JF; Blons H; Penault-Llorca F; Rougier P; Saint André JP; Emile JF
Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1430-7. PubMed ID: 23114745
[TBL] [Abstract][Full Text] [Related]
35. Tubular apocrine adenoma in association with syringocystadenoma papilliferum.
Aktepe F; Demir Y; Dilek FH
Dermatol Online J; 2003 Feb; 9(1):7. PubMed ID: 12639465
[TBL] [Abstract][Full Text] [Related]
36. Tubular apocrine adenoma and papillary eccrine adenoma. Entities or unity?
Fox SB; Cotton DW
Am J Dermatopathol; 1992 Apr; 14(2):149-54. PubMed ID: 1566975
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic Study of Sialadenoma Papilliferum of the Minor Salivary Glands: A Series of 8 New Cases With BRAF V600E Mutation-specific Immunohistochemical Analysis.
Owosho AA; Shasteen AM; Aguirre SE; Summersgill KF
Int J Surg Pathol; 2023 Oct; 31(7):1265-1272. PubMed ID: 36632022
[No Abstract] [Full Text] [Related]
38. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.
Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T
J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889
[TBL] [Abstract][Full Text] [Related]
39. Papillary eccrine adenoma with a pomegranate-like appearance.
Ambo M; Kumakiri M; Kobayashi H; Ohkawara A
J Dermatol; 1997 Dec; 24(12):773-6. PubMed ID: 9492441
[TBL] [Abstract][Full Text] [Related]
40. A Case of Tubular Apocrine Adenoma with Syringocystadenoma Papilliferum that Developed in a Nevus Sebaceus.
Kim MS; Lee JH; Lee WM; Son SJ
Ann Dermatol; 2010 Aug; 22(3):319-22. PubMed ID: 20711270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
